Severe acute respiratory distress syndrome (ARDS) related to SARS-COV-2 is resulting in increasing numbers of patients requiring mechanical ventilation. Although tracheostomy may reduce the duration of mechanical ventilation in these patients, it is considered a highly aerosol generating procedure and controversies regarding its safety, time of realization and indications remain to date. We share our experience about 5 cases of surgical tracheostomy in COVID-19 patients performed in our ICU.

Factor V congenital deficiency is a rare hereditary disease, it exposes patients to hemorrhagic risk, with high morbi-mortality. Its management is a real challenge for practitioners. Perioperative management of patients with Factor V congenital deficiency needs anesthetists, hematologists and surgeons to work in close collaboration.

The novel Coronavirus, named SARS-COV-2, is responsible of the COVID-19. It is a viral pneumonia that appeared in December 2019 in Wuhan, China, and is causing a pandemic. Most of patients present mild symptoms, but in many other patients, acute respiratory distress (ARDS) is more likely to be developped. The actual problematic is the appearance of cases with virus reactivation. We report a case of virus reactivation in a COVID-19 patient with ARDS.